Commission notes fall in problematic pharma deals
Just 10% of patent settlements in the pharmaceutical sector were problematic in the period July 2008 to December 2009, according to a report adopted by the European Commission
The figure compares with 22% in January 2000 to June 2008, the period covered by its recent enquiry into the pharmaceutical sector.
The Commission welcomed the findings of the report, saying it showed more awareness in the industry about which...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.